SMYD2 and cancer: A SET and MYND domain-containing histone (lysine) methyltransferase, SMYD2, methylates histone H3K4 and H3K36 and non-histone breast cancer associated proteins, including p53, Rb, HSP90 and estrogen receptor α (ERα)8–13.